Jaehee Lee1, Jae Kwang Lim2, Eun Jin Kim3, Deok Heon Lee4, Yu Kyung Kim5, Seung Soo Yoo1, Shin Yup Lee1, Seung Ick Cha1, Jae Yong Park1, Chang Ho Kim1. 1. Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea. 2. Department of Radiology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea. 3. Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu, Republic of Korea. 4. Department of Thoracic and Cardiovascular Surgery, School of Medicine, Kyungpook National University, Daegu, Republic of Korea. 5. Department of Clinical Pathology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Abstract
BACKGROUND: After the introduction of chemotherapy, miliary tuberculosis (TB) has been more prevalent in adults than in children. However, adult patients have a wide age range and may have different characteristics across the age span. Thus, clinical manifestations and treatment outcome may differ according to age groups in adult patients with miliary TB. However, there is limited information regarding this issue. METHODS: Adult patients with miliary TB were retrospectively reviewed and were categorized into young (18-40 years), middle-aged (41-64 years), and old adults (≥65 years). The clinical manifestations and treatment outcome were compared among the three adult groups. RESULTS: Of 150 patients, 27, 35, and 88 patients composed the young, middle-aged, and old adult groups, respectively. Overall clinical manifestations were comparable among the three groups. Treatment completion was significantly lower and overall TB deaths were significantly higher in the old group than in the young group. However, deaths in the young and middle-aged groups were all TB-related deaths, whereas deaths in the old group were more attributable to TB-unrelated deaths rather than TB-related deaths. In multivariate analysis, underlying chronic condition, lower hemoglobin levels, and acute respiratory failure were independent predictors for TB-related deaths in the adult group <65 years, and lower albumin levels and acute respiratory failure were those in the adult group ≥65 years. CONCLUSIONS: The present study suggests that treatment completion, the cause of death, and risk factors for TB-related deaths may be different according to age groups in adult patients with miliary TB.
BACKGROUND: After the introduction of chemotherapy, miliary tuberculosis (TB) has been more prevalent in adults than in children. However, adult patients have a wide age range and may have different characteristics across the age span. Thus, clinical manifestations and treatment outcome may differ according to age groups in adult patients with miliary TB. However, there is limited information regarding this issue. METHODS: Adult patients with miliary TB were retrospectively reviewed and were categorized into young (18-40 years), middle-aged (41-64 years), and old adults (≥65 years). The clinical manifestations and treatment outcome were compared among the three adult groups. RESULTS: Of 150 patients, 27, 35, and 88 patients composed the young, middle-aged, and old adult groups, respectively. Overall clinical manifestations were comparable among the three groups. Treatment completion was significantly lower and overall TB deaths were significantly higher in the old group than in the young group. However, deaths in the young and middle-aged groups were all TB-related deaths, whereas deaths in the old group were more attributable to TB-unrelated deaths rather than TB-related deaths. In multivariate analysis, underlying chronic condition, lower hemoglobin levels, and acute respiratory failure were independent predictors for TB-related deaths in the adult group <65 years, and lower albumin levels and acute respiratory failure were those in the adult group ≥65 years. CONCLUSIONS: The present study suggests that treatment completion, the cause of death, and risk factors for TB-related deaths may be different according to age groups in adult patients with miliary TB.
Entities:
Keywords:
Miliary tuberculosis; cause of death; risk factors for mortality; treatment outcome
Authors: H Al-Jahdali; K Al-Zahrani; P Amene; Z Memish; A Al-Shimemeri; M Moamary; A Alduhaim Journal: Int J Tuberc Lung Dis Date: 2000-03 Impact factor: 2.373
Authors: S F Hussain; M Irfan; M Abbasi; S S Anwer; S Davidson; R Haqqee; J A Khan; M Islam Journal: Int J Tuberc Lung Dis Date: 2004-04 Impact factor: 2.373
Authors: A Mert; M Bilir; F Tabak; R Ozaras; R Ozturk; H Senturk; H Aki; N Seyhan; T Karayel; Y Aktuglu Journal: Respirology Date: 2001-09 Impact factor: 6.424